These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis. Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158 [TBL] [Abstract][Full Text] [Related]
5. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. Lin L; Liu Y; Li H; Li PK; Fuchs J; Shibata H; Iwabuchi Y; Lin J Br J Cancer; 2011 Jul; 105(2):212-20. PubMed ID: 21694723 [TBL] [Abstract][Full Text] [Related]
6. Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy. MaruYama T; Kobayashi S; Shibata H; Chen W; Owada Y Cancer Sci; 2021 Dec; 112(12):4844-4852. PubMed ID: 34529884 [TBL] [Abstract][Full Text] [Related]
7. Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2. Murakami M; Ohnuma S; Fukuda M; Chufan EE; Kudoh K; Kanehara K; Sugisawa N; Ishida M; Naitoh T; Shibata H; Iwabuchi Y; Ambudkar SV; Unno M Drug Metab Dispos; 2017 Nov; 45(11):1166-1177. PubMed ID: 28904007 [TBL] [Abstract][Full Text] [Related]
8. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo. Shibata H; Yamakoshi H; Sato A; Ohori H; Kakudo Y; Kudo C; Takahashi Y; Watanabe M; Takano H; Ishioka C; Noda T; Iwabuchi Y Cancer Sci; 2009 May; 100(5):956-60. PubMed ID: 19445025 [TBL] [Abstract][Full Text] [Related]
9. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents. Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340 [TBL] [Abstract][Full Text] [Related]
11. Cationic Ester Prodrugs of Curcumin with N,N-dimethyl Amino Acid Promoieties Improved Poor Water Solubility and Intestinal Absorption. Hirano-Kusuda M; Setoguchi S; Koga M; Goto S; Yamada A; Watase D; Nagata-Akaho N; Karube Y; Matsunaga K; Takata J Pharm Res; 2023 May; 40(5):1299-1310. PubMed ID: 37081301 [TBL] [Abstract][Full Text] [Related]
12. A curcumin analogue GO-Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates. Suzuki M; Yamamoto Y; Nishijima-Matsunobu A; Kawasaki Y; Shibata H; Omori Y FEBS Open Bio; 2023 Mar; 13(3):434-446. PubMed ID: 36648092 [TBL] [Abstract][Full Text] [Related]
13. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas. Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924 [TBL] [Abstract][Full Text] [Related]
14. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage. Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064 [TBL] [Abstract][Full Text] [Related]
15. Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis. MaruYama T; Miyazaki H; Komori T; Osana S; Shibata H; Owada Y; Kobayashi S J Biochem; 2023 Nov; 174(6):511-518. PubMed ID: 37656908 [TBL] [Abstract][Full Text] [Related]
16. Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo. Liu T; Yuan X; Jia T; Liu C; Ni Z; Qin Z; Yuan Y Int J Pharm; 2016 Jun; 506(1-2):382-93. PubMed ID: 27132167 [TBL] [Abstract][Full Text] [Related]
17. The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice. Shimizu K; Sunagawa Y; Funamoto M; Wakabayashi H; Genpei M; Miyazaki Y; Katanasaka Y; Sari N; Shimizu S; Katayama A; Shibata H; Iwabuchi Y; Kakeya H; Wada H; Hasegawa K; Morimoto T Sci Rep; 2020 Apr; 10(1):7172. PubMed ID: 32346115 [TBL] [Abstract][Full Text] [Related]
18. A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin. Muangnoi C; Jithavech P; Ratnatilaka Na Bhuket P; Supasena W; Wichitnithad W; Towiwat P; Niwattisaiwong N; Haworth IS; Rojsitthisak P Biosci Biotechnol Biochem; 2018 Aug; 82(8):1301-1308. PubMed ID: 29678124 [TBL] [Abstract][Full Text] [Related]
19. Efficient Synthesis of Polymer Prodrug by Thiol-Acrylate Michael Addition Reaction and Fabrication of pH-Responsive Prodrug Nanoparticles. Xu CR; Qiu L; Pan CY; Hong CY; Hao ZY Bioconjug Chem; 2018 Sep; 29(9):3203-3212. PubMed ID: 30075069 [TBL] [Abstract][Full Text] [Related]
20. Is prodrug design an approach to increase water solubility? Sanches BMA; Ferreira EI Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]